Abstract
BackgroundCertolizumab pegol (CZP) is the only antiTNF pegylated without Fc available for patients with psoriatic arthritis (PsA). The efficacy and safety of CZP in clinical trials is known, but there...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have